Plains GP Holdings, L.P. (NYSE:PAGP - Get Free Report) has been given an average recommendation of "Hold" by the nine research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $20.50.
Several equities research analysts have recently commented on the company. Morgan Stanley cut their price objective on Plains GP from $22.00 to $20.00 and set an "equal weight" rating for the company in a report on Tuesday, August 26th. Mizuho raised their price target on Plains GP from $20.00 to $22.00 and gave the company an "outperform" rating in a report on Wednesday, June 18th. JPMorgan Chase & Co. cut their price target on Plains GP from $21.00 to $20.00 and set a "neutral" rating for the company in a report on Thursday, September 18th. Wolfe Research reaffirmed a "peer perform" rating on shares of Plains GP in a report on Friday, July 25th. Finally, Zacks Research downgraded Plains GP from a "strong-buy" rating to a "hold" rating in a report on Monday, September 15th.
View Our Latest Stock Analysis on Plains GP
Plains GP Trading Down 0.5%
NYSE PAGP opened at $18.21 on Friday. The company has a market cap of $3.60 billion, a PE ratio of 34.36 and a beta of 0.68. The company has a current ratio of 1.01, a quick ratio of 0.92 and a debt-to-equity ratio of 0.49. Plains GP has a 12 month low of $16.60 and a 12 month high of $22.31. The stock has a 50 day moving average of $18.89 and a 200-day moving average of $19.03.
Plains GP Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 31st will be issued a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 8.3%. Plains GP's dividend payout ratio is 220.29%.
Institutional Investors Weigh In On Plains GP
Several hedge funds have recently added to or reduced their stakes in the business. Corient Private Wealth LLC lifted its holdings in Plains GP by 3.3% during the 2nd quarter. Corient Private Wealth LLC now owns 241,961 shares of the pipeline company's stock valued at $4,701,000 after purchasing an additional 7,823 shares during the last quarter. Osaic Holdings Inc. increased its position in Plains GP by 75.3% during the 2nd quarter. Osaic Holdings Inc. now owns 291,320 shares of the pipeline company's stock worth $5,661,000 after buying an additional 125,169 shares during the period. Advisory Services Network LLC increased its position in Plains GP by 17.7% during the 2nd quarter. Advisory Services Network LLC now owns 75,451 shares of the pipeline company's stock worth $1,479,000 after buying an additional 11,326 shares during the period. Asset Dedication LLC bought a new position in Plains GP during the 2nd quarter worth $83,000. Finally, Evergreen Capital Management LLC increased its position in Plains GP by 3.3% during the 2nd quarter. Evergreen Capital Management LLC now owns 740,252 shares of the pipeline company's stock worth $14,383,000 after buying an additional 23,554 shares during the period. Institutional investors and hedge funds own 88.30% of the company's stock.
About Plains GP
(
Get Free Report)
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plains GP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plains GP wasn't on the list.
While Plains GP currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.